Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Reference39 articles.
1. Gupta AK, Paquet M, Villanueva E, Brintnell W. Interventions for actinic keratoses. Cochrane Database Syst Rev. 2012;12:CD004415.
2. de Berker D, McGregor JM, Mohd Mustapa MF, Exton LS, Hughes BR. British Association of Dermatologists’ guidelines for the care of patients with actinic keratosis 2017. Br J Dermatol. 2017;176(1):20–43.
3. Dodson JM, DeSpain J, Hewett JE, Clark DP. Malignant potential of actinic keratoses and the controversy over treatment: a patient-oriented perspective. Arch Dermatol. 1991;127(7):1029–31.
4. Primary Care Dermatology Society. Actinic keratosis (syn. solar keratosis). 2022. https://www.pcds.org.uk/clinical-guidance/actinic-keratosis-syn-solar-keratosis. Accessed 18 Dec 2022.
5. National Institute of Health and Care Excellence. British National Formulary. 2021. https://bnf.nice.org.uk/. Accessed 18 Dec 2022.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献